Recent Virtual DRK-12 Sessions: Recordings and Slides

View recording, slides and resources from the five webinars hosted by CADRE this spring: 

  • Adapting Your DRK-12 Research Amid the COVID-19 Pandemic | May 19, 2020 | 2:00-3:00 PM ET
    Beth Herbel-EisenmannRob OchsendorfLaura O'Dwyer, and Alan Stockdale led an online discussion about the implications of COVID-19 on DRK-12 research, including approaches to adapting current projects and designing new studies that respond to the limitations and opportunities we are currently experiencing due to the coronavirus pandemic. Participants asked questions and shared ideas related to redesigning research (while still addressing your goals and original questions), IRB issues such as security and risk, stopping and restarting research, and more. 

  • Informational Webinar on DRK-12 Solicitation (20-572) | May 20, 2020 | 2:00-3:00 PM ET
    NSF program directors Rob Ochsendorf and Mike Steele presented on the revised DRK-12 Solicitation (20-572), giving an overview of the revisions and sharing important information and key takeaways from the solicitation. 
  • Managing Your NSF Grant | May 27, 2020 | 1:00-2:30 PM ET
    NSF grants and program officers led a session on NSF grant policies and grant management procedures. Topics covered included personnel, budgets, notifications and requests, and preparing high quality annual and final reports. 
  • Strengthening Educators' Practices for Engaging and Empowering Students with Disabilities and Difficulties as Mathematics Learners |June 4, 2020 | 1:00-2:00 PM ET
    Amy BrodeskyJessica Hunt, Karen Mutch-Jones and Judy Storeygard shared key components, successes, and challenges of asset-based PD in mathematics. The webinar focused on the pressing question: What are ways to support educators in providing high-quality, inclusive instruction that empowers students with disabilities/difficulties as mathematics thinkers and doers?

 These resources are also available on the event pages, and added as to our resource library, DRK-12 Research and Products.